RCS - Kanabo Group PLC - Company Webinar

KanaboAnnouncement

22/02/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220222:nRSV3481Ca&default-theme=true

RNS Number : 3481C  Kanabo Group PLC  22 February 2022

Kanabo Group Plc

("Kanabo" or the "Company")

 

Webinar and Q&A

 

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company
focussing on the development and distribution of cannabis-derived products for
medical patients and wellness CBD consumers, announces it will hold a company
webinar via Vox Markets on Wednesday 23 February 2022 at 5.30pm (GMT).

 

Following the announcement made yesterday of the acquisition of the GP Service
Limited (the "GP Service"), a UK-based private primary care telemedicine
provider, Avihu Tamie, CEO of Kanabo, and Atul Devani, Executive Chairman and
co-founder of the GP Service, will host a webinar to discuss the strategic
acquisition.

 

Highlights:

·    The GP Service is an approved provider on the NHS digital framework
for video and on-line consultations

·    The GP Service is able to able to electronically deliver
prescriptions to a network of 4,200 pharmacies including major high street
chains and independent pharmacies

·    The GP Service provides online GP video consultation services to
corporate clients as an occupational health service for employers as well as
pharmacies, including a major high street pharmacy chain

·    Kanabo intends to develop The GP Service platform to become one of
Europe's first digitally led and legally compliant providers for Kanabo's
products and wellness CBD services following regulatory approval

·    The acquisition will facilitate the rapid growth of the GP Service
existing digital and telemedicine business and will establish a new and fully
compliant channel to market for Kanabo's products

 

This webinar is open to all, subject to registration. To register and submit
questions prior to the event, please use the following link:

https://voxmarkets.brand.live/c/kanabo-webinar
(https://voxmarkets.brand.live/c/kanabo-webinar)

 

Those who follow Kanabo Group plc on the Vox Markets platform will
automatically be invited.

 

 

For further information, please visit http://www.kanabogroup.com/ or contact
the following:

 Kanabo Group Plc                            Via Vox Markets
 Avihu Tamir, CEO
 Peterhouse Capital Ltd (Financial Adviser)  Tel: +44 (0)20 7469 0930
 Eran Zucker / Lauren Riley
 Peterhouse Capital Ltd (Corporate Broker)   Tel: +44 (0)20 7469 0930
 Lucy Williams / Charles Goodfellow / Duncan Vasey / Martin Lampshire
 Vox Markets (Investor Relations)            KanaboGroup@voxmarkets.co.uk
 Kat Perez                                   kperez@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry
to improve the well-being of millions of people around the world by providing
a better alternative to the smoking of medicinal cannabis flowers. Kanabo,
which was the first medicinal cannabis company to IPO on London Stock
Exchange, has a focus on the distribution of cannabis-derived products for
medical patients and non-THC products for CBD consumers. It has conducted
extensive Research & Development to produce high-quality cannabis extract
formulas, innovative medical-grade vaporizers, and various non-smoking
consumption solutions. Kanabo sells a range of medical cannabis products and
wellness CBD products in the Primary Markets, including its VapePod, which
delivers a metered dose with every inhalation.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUAARRUOUUUUR